|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | |||||||||||
| Prepaid expenses | |||||||||||
| Short-term investments | |||||||||||
| Prepaid expenses and other current assets | |||||||||||
| Restricted cash | |||||||||||
| Total current assets | |||||||||||
| Deferred offering costs associated with initial public offering | |||||||||||
| Investments held in Trust Account | |||||||||||
| Property and equipment, net | |||||||||||
| Restricted cash | |||||||||||
| Right-of-use asset | |||||||||||
| Other investments | |||||||||||
| Other non-current assets | |||||||||||
| Total assets | |||||||||||
| Liabilities and Stockholders' Equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | |||||||||||
| Accrued expenses | |||||||||||
| Franchise tax payable | |||||||||||
| Lease liability, current | |||||||||||
| Total current liabilities | |||||||||||
| Deferred underwriting commissions | |||||||||||
| Derivative warrant liabilities | |||||||||||
| Non-current liabilities: | |||||||||||
| Contingent earn-out liability | |||||||||||
| Warrant liabilities | |||||||||||
| Lease liability, non-current | |||||||||||
| Restricted stock repurchase liability | |||||||||||
| Total liabilities | |||||||||||
| Class A common stock subject to possible redemption, $0.0001 par value; 55,200,000 shares at $10.00 per share | |||||||||||
| Stockholders' equity: | |||||||||||
| Common stock, $0.0001 par value; 1,250,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 537,540,870 and 538,549,210 shares issued as of September 30, 2023 and December 31, 2022, respectively; and 484,965,823 and 478,674,305 shares outstanding at September 30, 2023 and December 31, 2022, respectively | |||||||||||
| Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 13,800,000 shares issued and outstanding | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated other comprehensive income (loss) | |||||||||||
| Accumulated deficit | |||||||||||
| Total Stockholders’ Deficit | |||||||||||
| Total stockholders' equity | |||||||||||
| Total liabilities and stockholders' equity |
Loading...
